Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Amgen's new Enbrel patent could delay biosims for 17 years
Amgen's new Enbrel patent could delay biosims for 17 years
Amgen's new Enbrel patent could delay biosims for 17 years
Submitted by
admin
on November 23, 2011 - 1:11pm
Source:
Fierce Pharma
News Tags:
Enrbrel
Amgen
biosimilars
Merck
anti-inflammatory
Headline:
Amgen's new Enbrel patent could delay biosims for 17 years
Do Not Allow Advertisers to Use My Personal information
